Teleflex Incorporated (TFX) — RQD Stock Rating Cockpit

$139.77 -1.15% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $139.22

Teleflex Incorporated (TFX) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $5.99B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on TFX Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is TFX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Teleflex Incorporated (NYSE: TFX) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $139.77 (-1.15% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, TFX ranks #318 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does TFX compare to MMSI and STVN in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), TFX carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 56.2%, and ROIC of 1.8%. By comparison, MMSI (Merit Medical Systems Inc.) holds a B grade (75/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.58B) and STVN (Stevanato Group S.p.A.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $5.53B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for TFX?
▼

Per TFX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000096943), Teleflex Incorporated generated $1.99B in revenue (+17.2% YoY), -$905.6M in net income, and $0 in free cash flow against $6.95B in total assets and $2.54B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $139.21 (-0.40%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 1.5% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510048
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D
Cash (6)Whales (17)SEC (9)Macro (11)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-4.5% Base Target
$158 Bull$133 Base$104 Bear
📬 FREE TFX RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TFX)Realized 20D OHLCV Swing Band: ±5.6%
Deterministic 5-Pillar Attribution (48/100 Composite)
🔍 WHY TFX SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+17/20 pts (35% of score)

20D Institutional Volume Accumulation (±5.6% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+11/20 pts (23% of score)

FRED Regime × Technicals: 88% of 52W Range • RSI-14 at 70.2 (OVERBOUGHT (>70))

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$124.44+5.4% Next Q
Q2 (-2Q)
43
Grade D$131.15+6% Next Q
Q3 (-1Q)
45
Grade D$139.00+0.6% Next Q
Current
48
Grade D$139.77-5.6% Hist 90D α
Trajectory: D (40) → D (48)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a TFX Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While TFX currently carries a cautious 48/100 (D) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Big institutional funds and options desks are actively positioning on the bullish side.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($131.45) and Max Pain ($146.76) forces dealer call-delta covering toward $157.51.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $TFX• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “TFX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMOVERBOUGHT (>70)
70.230 Oversold · 70 Hot
ALTMAN-Z SHIELDWATCH ZONE (1.8–3.0)
2.12>3.0 Fortress Safe
PIOTROSKI F-SCOREWEAK QUALITY (1–4)
4 / 99-Pt Accounting
52-WEEK LASER RANGE88% OF RANGE
L: $100$139.77H: $145
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 6 / 20
2. Big Money & Insiders● NEUTRAL
Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: D+RQD 22 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 20 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on TFX

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (30)

1.8% ROIC with 56.2% gross margin and -18.00% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (45)

Altman-Z 2.12 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
NEUTRAL (55)

22/40 institutional & smart-money positioning score with 11/20 macro alignment.

Bull Case: Why Buyers Like TFX
  • ✓Big institutional funds and options desks are actively positioning on the bullish side.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TFX)

  • ✓Walkthrough of TFX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
TFX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +16.58%📐 HORIZONTAL RANGE
2026-11-02O $139.0H $141.4L $139.0C $139.8VOL 838.0K
RES: $142.8SUP: $117.3SMA50: $131.5SMA200: $125.5
$146.9$139.1$131.4$123.6$115.9RES $142.8SUP $117.3$139.82026-05-042026-06-172026-08-042026-09-182026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TFX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
20.6%/yr Implied 5Y Growth

vs. +17.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TFX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TFX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for TFX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TFX)

Health Care Rank #318 of 1016 ⚔️ MMSI vs TFX Full Matrix →

1. Head-to-Head Health Care Peer Comparison (TFX vs. MMSI, STVN, HAE, MMED)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Teleflex Incorporated (TFX) ranks #318 by composite RQD confidence (48/100, grade D) and #147 by equity capitalization ($5.99B). Within this direct 5-issuer industry benchmark cohort, MMSI leads on earnings valuation at 43.4x trailing P/E, while HAE leads on capital efficiency and profitability with 8.4% ROIC and 59.0% gross margin. MMSI currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with TFX at 48/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
TFX ACTIVE
Teleflex Incorporated
D 48/100 — 56.2% 1.8% -1.15% $5.99B Benchmark Subject
MMSI
Merit Medical Systems Inc.
B 75/100 43.4x 48.7% 7.8% -7.66% $5.58B /mmsi-vs-tfx →
STVN
Stevanato Group S.p.A.
D+ 58/100 — — — -4.25% $5.53B /stvn-vs-tfx →
HAE
Haemonetics Corporation
B 74/100 — 59.0% 8.4% -0.12% $5.45B /hae-vs-tfx →
MMED
MiniMed Group Inc.
D 46/100 — 54.2% -3.9% -5.04% $5.42B /mmed-vs-tfx →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000096943

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Teleflex Incorporated (TFX) reported GAAP revenue of $1.99B (+17.2% vs. FY2024 revenue of $1.70B , and +16.4% cumulative change since FY2023) , GAAP net income of -$905.6M, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, TFX closed FY2025 with $6.95B in total assets against $2.54B in total debt (Altman Z-Score: 2.12, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.99B -$905.6M — — $6.95B $2.54B
FY2024 (FY) 2024-12-31 $1.70B $70.2M — — $7.10B $1.56B
FY2023 (FY) 2023-12-31 $1.71B $357.6M — — $3.30B $771.0M

3. TFX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TFX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Teleflex Incorporated (NYSE: TFX) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $139.77 (-1.15% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, TFX ranks #318 in composite RQD confidence.

How does TFX compare to MMSI and STVN in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), TFX carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 56.2%, and ROIC of 1.8%. By comparison, MMSI (Merit Medical Systems Inc.) holds a B grade (75/100 RQD, P/E 43.4x, ROIC 7.8%, cap $5.58B) and STVN (Stevanato Group S.p.A.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $5.53B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for TFX?

Per TFX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000096943), Teleflex Incorporated generated $1.99B in revenue (+17.2% YoY), -$905.6M in net income, and $0 in free cash flow against $6.95B in total assets and $2.54B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is TFX trading relative to its 50-day, 200-day, and 52-week technical levels?

TFX last traded at $139.77 (-1.15% on volume of 891,302 shares), positioning the stock +6.33% above its 50-day simple moving average ($131.45) and +11.34% above its 200-day simple moving average ($125.54). Across its 52-week range of $100.18 to $145.00, TFX sits at the 88.3% percentile with a 14-day RSI of 70.2 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.6% ($131.94 to $147.60).

TFX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell TFX stock right now?

Teleflex Incorporated (TFX) currently earns a Roarable Rating of D (Sell — SELL) with 48/100 RQD Confidence. Stretched risk/reward at current multiples (2% return on capital) under elevated 10-year interest-rate pressure.

What is TFX's 12-month price target and RQD AI Jury consensus?

TFX's 12-month base price target is $133.48 (range $104.11 to $157.51), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

ROARABLE RATING BRIEF • RQD 48/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

TFX — Teleflex Incorporated: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:19:33Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, TFX scores 48 out of 100, a grade of D, with the verdict "Roarable Sell — Underperform / Distribution Warning." The Fundamental Cash Engine pillar scores 6 out of 20, reflecting ROIC of 1.8% and an FCF yield of -18%; this is the weakest pillar and indicates the business is not currently generating attractive returns on invested capital or positive free cash flow. The Whale 13F Flow pillar scores 17 out of 20, the strongest pillar, reflecting institutional accumulation and options positioning. Insider Conviction scores 5 out of 20, reflecting SEC Form 4 and Congressional PTR cluster flow that the rating characterizes as weak. Macro Regime Fit scores 11 out of 20, with a Beta of 0.98 and a sector sensitivity profile. Forensic Balance Sheet scores 9 out of 20, reflecting an Altman Z of 2.12, a Piotroski F of 4 out of 9, and Debt/Equity of 0.81.

For a prospective investor, the upside case rests mainly on the institutional positioning signal, which is the only pillar near the top of its range. The valuation tradeoff is significant: per the market data, forward P/E is 27 and EV/EBITDA is 40.9 against trailing EPS of -21.37, so the price embeds expectations that the reported cash-generation weakness must reverse. The rating's overall framing is a distribution warning rather than an accumulation signal, meaning the weak fundamental and insider pillars outweigh the institutional flow reading. This is an analytical summary of the source data, not personalized financial advice.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025 (filed 2025-12-31)$1992.7M$118.4M$-905.6MN/AN/A$378.6M$2541.4M
FY 2024 (filed 2024-12-31)$1699.5M$103.7M$70.2MN/AN/A$247.9M$1555.9M
FY 2023 (filed 2023-12-31)$1712.4M$258.7M$357.6MN/AN/AN/A$771.0M

Per the SEC financials, revenue rose from $1712.4M in FY 2023 to $1992.7M in FY 2025, while net income moved from $357.6M to $-905.6M over the same span. Per the market data, operating margin is 5.9% and net margin is -45.4%, and ROIC is 1.8%. Per the Roarable RQD rating, the Altman Z-Score is 2.12, the Piotroski F-Score is 4 out of 9, and Debt/Equity is 0.81. Debt rose from $771.0M in FY 2023 to $2541.4M in FY 2025 per the SEC financials.

Recent Catalysts & News Wire Analysis

The news wire contains six items, each labeled YELLOW with impact label MARKET WIRE. The headlines reference a MarketBeat "Moderate Buy" rating by Wall Street brokerages, a Yahoo Finance forecast item, a research-oriented MarketBeat item, a Yahoo Finance Singapore overview, a price-action item reporting TFX ticking up 0.80% to $129.24 with a negative gamma reference, and a report that State of Alaska Department of Revenue sold TFX shares. The price-action item's summary field contains an unrelated domain reference rather than analysis, and the source label is also a non-financial domain, so its reliability is limited. No proprietary signals are present in the Butterfly graph. Risk watch items per the financials include the net loss in FY 2025 and the rise in debt.

Open Questions

  • What is the composition of the FY 2025 net loss of $-905.6M, and does the source data identify any one-time items?
  • What is FCF and EPS for any reported period, given that both are N/A in every financials row?
  • What products and customers generate the $1992.7M of FY 2025 revenue?
  • What is the trailing P/E, given the market data reports it as unavailable while EPS is negative?
  • Who holds the institutional and insider positions behind the 17/20 Whale 13F Flow pillar?

TFX Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Teleflex Incorporated (TFX) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to TFX Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

TFX Bull vs. Bear Conversation Board — What's Your Call at $139.77?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON TFX 🐻 50% BEARISH CONVICTION
1. Pick Your Side on TFX:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $152.70 (+8.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is TFX (D • RQD 48/100) a Buy at $141.39?

Welcome to the TFX (Teleflex Incorporated) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell — Underperform / Distribution Warning) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $110.28 (-22.0%)
Spot @ $141.39

Pump the brakes on TFX — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on TFX, but look at what you are paying: current EV/EBITDA multiples with 56.2% gross margins. Unless Teleflex Incorporated expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader 🐂 BULLISH 🎯 Target: $162.60 (+15.0%)
Spot @ $141.39

TFX cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on TFX, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $141.39 (52-wk range $100.18 - $145.00), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%